PNC FINANCIAL SERVICES GROUP, INC. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$3,633
+257.2%
189
+372.5%
0.00%
Q2 2023$1,017
-74.2%
40
-63.3%
0.00%
Q1 2023$3,941
-17.1%
109
-9.2%
0.00%
Q4 2022$4,752
-32.1%
120
-21.1%
0.00%
Q3 2022$7,0000.0%1520.0%0.00%
Q2 2022$7,000
-12.5%
152
+38.2%
0.00%
Q1 2022$8,000
-27.3%
110
-18.5%
0.00%
Q4 2021$11,000
-35.3%
135
-10.6%
0.00%
Q3 2021$17,000
-48.5%
151
-24.5%
0.00%
Q2 2021$33,000
+26.9%
200
+11.7%
0.00%
Q1 2021$26,000
+8.3%
179
+28.8%
0.00%
Q4 2020$24,000
+26.3%
139
+5.3%
0.00%
Q3 2020$19,000
+18.8%
1320.0%0.00%
Q2 2020$16,000
+33.3%
132
+12.8%
0.00%
Q1 2020$12,000
-14.3%
117
-1.7%
0.00%
Q4 2019$14,000
+27.3%
1190.0%0.00%
Q3 2019$11,000
+450.0%
119
+340.7%
0.00%
Q2 2019$2,0000.0%270.0%0.00%
Q1 2019$2,000
+100.0%
270.0%0.00%
Q4 2018$1,00027
+440.0%
0.00%
Q3 2018$0
-100.0%
5
-61.5%
0.00%
Q2 2018$1,000
-99.6%
13
-99.5%
0.00%
Q3 2017$238,000
+25.3%
2,627
+3.4%
0.00%
Q2 2017$190,000
+2614.3%
2,540
+2753.9%
0.00%
Q2 2016$7,000
+40.0%
89
-4.3%
0.00%
Q1 2016$5,000
-16.7%
93
+3.3%
0.00%
Q4 2015$6,000
+50.0%
900.0%0.00%
Q3 2015$4,000
+100.0%
90
+95.7%
0.00%
Q2 2015$2,000
+100.0%
46
+76.9%
0.00%
Q1 2015$1,000260.00%
Other shareholders
NEVRO CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders